TAGALONG Trial: Phase II Study of TAGraxofusp and Azacitidine With or Without Venetoclax in Newly Diagnosed Secondary AML after Previous Exposure to HypOmethylatiNG Agents

Status: Open to Accrual

Learn more:

• https://clinicaltrials.gov/study/NCT05442216

Study Contact: studies@hoosiercancer.org; (317) 921-2050.